MA43682A - Procédés de traitement de l'intolérance au lactose - Google Patents

Procédés de traitement de l'intolérance au lactose

Info

Publication number
MA43682A
MA43682A MA043682A MA43682A MA43682A MA 43682 A MA43682 A MA 43682A MA 043682 A MA043682 A MA 043682A MA 43682 A MA43682 A MA 43682A MA 43682 A MA43682 A MA 43682A
Authority
MA
Morocco
Prior art keywords
treatment methods
lactose intolerance
intolerance treatment
lactose
methods
Prior art date
Application number
MA043682A
Other languages
English (en)
Inventor
Salvatore Bellinvia
Marie Mcnulty
Francesca Viti
Original Assignee
Nogra Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nogra Pharma Ltd filed Critical Nogra Pharma Ltd
Publication of MA43682A publication Critical patent/MA43682A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
MA043682A 2016-02-26 2017-02-27 Procédés de traitement de l'intolérance au lactose MA43682A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662300376P 2016-02-26 2016-02-26

Publications (1)

Publication Number Publication Date
MA43682A true MA43682A (fr) 2018-11-28

Family

ID=58162625

Family Applications (1)

Application Number Title Priority Date Filing Date
MA043682A MA43682A (fr) 2016-02-26 2017-02-27 Procédés de traitement de l'intolérance au lactose

Country Status (6)

Country Link
US (1) US20190046490A1 (fr)
EP (1) EP3419616A1 (fr)
JP (1) JP7125350B2 (fr)
CA (1) CA3014575A1 (fr)
MA (1) MA43682A (fr)
WO (1) WO2017144725A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20170936T1 (hr) 2009-02-16 2017-09-22 Nogra Pharma Limited Alkilamido spojevi i njihova uporaba
WO2013117744A2 (fr) 2012-02-09 2013-08-15 Nogra Pharma Limited Méthodes de traitement de la fibrose
AU2020217884B2 (en) 2019-02-08 2025-02-20 Nogra Pharma Limited Process of making 3-(4'-aminophenyl)-2-methoxypropionic acid, and analogs and intermediates thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8302708D0 (en) * 1983-02-01 1983-03-02 Efamol Ltd Pharmaceutical and dietary composition
US7015249B1 (en) * 1997-12-12 2006-03-21 Purdue Research Foundation Methods and compositions for treating diabetes
WO1999029317A1 (fr) 1997-12-12 1999-06-17 Purdue Research Foundation Methodes et compositions de traitement du diabete
WO2003043569A2 (fr) * 2001-11-16 2003-05-30 Nutrition 21, Inc. Isomere d'acide linoleique conjugue trans-10, cis-12 permettant de traiter le diabete, de reduire l'adiposite, d'ameliorer la sensibilite a l'insuline, de reduire l'hypercholesterolemie et de traiter l'atherosclerose
EP1719543A1 (fr) * 2005-05-04 2006-11-08 Asan Labs., Ltd. Utilisation d'inhibiteurs d'histone deacetylase pour le traitement de problèmes gastro-intestinaux
WO2007096148A1 (fr) * 2006-02-23 2007-08-30 Lipid Nutrition B.V. Immunorégulation
IE20070129A1 (en) 2007-02-28 2008-12-24 Giuliani Int Ltd Ppar-gamma agonists stimulate enteric defensin expression
US20090264520A1 (en) * 2008-04-21 2009-10-22 Asha Lipid Sciences, Inc. Lipid-containing compositions and methods of use thereof
SI3121280T1 (sl) 2008-11-13 2025-08-29 Nogra Pharma Limited Antismiselne sestave in postopki za njihovo izdelavo ter uporabo
NZ631049A (en) 2012-04-18 2017-02-24 Nogra Pharma Ltd Methods of treating lactose intolerance
JP6096179B2 (ja) * 2012-05-10 2017-03-15 国立大学法人岩手大学 ラクターゼ活性を有するタンパク質、該タンパク質をコードする遺伝子、該遺伝子を含有する組み換えベクター、形質転換体、及びその製造方法並びに用途
US20160045523A1 (en) * 2013-03-26 2016-02-18 Lipid Therapeutics Gmbh Pharmaceutical formulation comprising phosphatidylcholine for the treatment of ulcerative colitis

Also Published As

Publication number Publication date
CA3014575A1 (fr) 2017-08-31
WO2017144725A1 (fr) 2017-08-31
US20190046490A1 (en) 2019-02-14
JP2019510745A (ja) 2019-04-18
JP7125350B2 (ja) 2022-08-24
EP3419616A1 (fr) 2019-01-02

Similar Documents

Publication Publication Date Title
MA45192A (fr) Traitement d'association
MA47208A (fr) Procédés de traitement du cancer à l'aide d'anticorps anti-pd-1
EP3496739A4 (fr) Compositions et procédés de traitement de l'hypertension pulmonaire
MA55748A (fr) Procédés de détection d'aav
EP3426250A4 (fr) Procédés de traitement
EP3433815A4 (fr) Traitement d'authentification adaptable
IL269490B (en) Surface treatment methods and compositions therefor
EP3601536A4 (fr) Procédés de traitement
EP3443094A4 (fr) Procédés de réduction de l'expression de c9orf72
HUE053239T2 (hu) Humanizált tau-ellenanyagok Alzheimer-kór kezelésére
FR3036037B1 (fr) Harnais d'encordement perfectionne
EP3390642A4 (fr) Compositions et procédés pour le traitement de rétinite pigmentaire 18 et de rétinite pigmentaire 13
EP3625971A4 (fr) Traitement d'audio spatial
EP3341391A4 (fr) Compositions et procédés pour le traitement de la douleur
EP3389657A4 (fr) Procédés de traitement de l'hyperalgésie
EP3331542A4 (fr) Compositions et procédés pour traiter des cancers associés à l'activation d'etbr
EP3433383A4 (fr) Procédés d'amplification quantitative
EP3409744A4 (fr) Agent de traitement de surface
MA46062A (fr) Traitement par ascaroside de l'oesophagite à éosinophiles
EP3558312A4 (fr) Procédés d'amélioration de la densité vasculaire
EP3431566A4 (fr) Agent de traitement de surface
IL263433A (en) Methods for treating alzheimer's disease
MA47437A (fr) Procédés de traitement d'infections fongiques
IL262588A (en) Humanized anti-basigin antibodies and the use thereof
EP3402575A4 (fr) Procédés et compositions pour le traitement de cheveux endommagés